menin inhibitor DSP-5336
Term · Oncology and biomedicine · MLC-T-ONC-015092
An orally bioavailable, small molecule inhibitor of menin, with potential antineoplastic activity. Upon oral administration, menin inhibitor DSP-5336 targets and binds to the nuclear protein menin, thereby preventing the interaction between the two proteins menin and menin-mixed lineage leukemia (MLL; myeloid/lymphoid leukemia; KMT2A) and the formation of the menin-MLL complex. This reduces the expression of downstream target genes and results in an inhibition of the proliferation of MLL-rearranged leukemic cells. The menin-MLL complex plays a key role in the survival, growth, transformation and proliferation of certain kinds of leukemia cells.
| Identifier | MLC-T-ONC-015092 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | menin-MLL interaction inhibitor DSP-5336 |
| References | National Cancer Institute Thesaurus (CC BY 4.0) |
Record as JSON
{
"id": "MLC-T-ONC-015092",
"term": "menin inhibitor DSP-5336",
"field": "Oncology and biomedicine",
"definition": "An orally bioavailable, small molecule inhibitor of menin, with potential antineoplastic activity. Upon oral administration, menin inhibitor DSP-5336 targets and binds to the nuclear protein menin, thereby preventing the interaction between the two proteins menin and menin-mixed lineage leukemia (MLL; myeloid/lymphoid leukemia; KMT2A) and the formation of the menin-MLL complex. This reduces the expression of downstream target genes and results in an inhibition of the proliferation of MLL-rearranged leukemic cells. The menin-MLL complex plays a key role in the survival, growth, transformation and proliferation of certain kinds of leukemia cells.",
"synonyms": [
"menin-MLL interaction inhibitor DSP-5336"
],
"references": [
"National Cancer Institute Thesaurus"
],
"url": "https://mlchart.com/terminology/oncology/menin-inhibitor-dsp-5336/"
}
Record 10,835 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.